Cardiovascular Ultrasound Market Size, Share, and Trends 2024 to 2034

The global cardiovascular ultrasound market size is estimated at USD 3.01 billion in 2025 and is forecasted to reach around USD 5.3 billion by 2034, accelerating at a CAGR of 6.51% from 2025 to 2034. The North America cardiovascular ultrasound market size reached USD 870 million in 2024 and is expanding at a CAGR of 6.54% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : April 2025
  • Report Code : 2036
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cardiovascular Ultrasound Market 

5.1. COVID-19 Landscape: Cardiovascular Ultrasound Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cardiovascular Ultrasound Market, By Type

8.1. Cardiovascular Ultrasound Market, by Type

8.1.1. Transthoracic Echocardiography

8.1.1.1. Market Revenue and Forecast

8.1.2. Transoesophageal Echocardiography

8.1.2.1. Market Revenue and Forecast

8.1.3. Foetal Echocardiography

8.1.3.1. Market Revenue and Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Cardiovascular Ultrasound Market, By Technology

9.1. Cardiovascular Ultrasound Market, by Technology

9.1.1. 2D

9.1.1.1. Market Revenue and Forecast

9.1.2. 3D/4D

9.1.2.1. Market Revenue and Forecast

9.1.3. Doppler

9.1.3.1. Market Revenue and Forecast

9.1.4. Others

9.1.4.1. Market Revenue and Forecast

Chapter 10. Global Cardiovascular Ultrasound Market, By Display 

10.1. Cardiovascular Ultrasound Market, by Display

10.1.1. Black & White (B/W)

10.1.1.1. Market Revenue and Forecast

10.1.2. Color

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Cardiovascular Ultrasound Market, By End-use 

11.1. Cardiovascular Ultrasound Market, by End-use

11.1.1. Hospital

11.1.1.1. Market Revenue and Forecast

11.1.2. Diagnostic Centers

11.1.2.1. Market Revenue and Forecast

11.1.3. Ambulatory Care Centers

11.1.3.1. Market Revenue and Forecast

11.1.4. Others

11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Cardiovascular Ultrasound Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type

12.1.2. Market Revenue and Forecast, by Technology

12.1.3. Market Revenue and Forecast, by Display

12.1.4. Market Revenue and Forecast, by End-use

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type

12.1.5.2. Market Revenue and Forecast, by Technology

12.1.5.3. Market Revenue and Forecast, by Display

12.1.5.4. Market Revenue and Forecast, by End-use

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type

12.1.6.2. Market Revenue and Forecast, by Technology

12.1.6.3. Market Revenue and Forecast, by Display

12.1.6.4. Market Revenue and Forecast, by End-use

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type

12.2.2. Market Revenue and Forecast, by Technology

12.2.3. Market Revenue and Forecast, by Display

12.2.4. Market Revenue and Forecast, by End-use

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type

12.2.5.2. Market Revenue and Forecast, by Technology

12.2.5.3. Market Revenue and Forecast, by Display

12.2.5.4. Market Revenue and Forecast, by End-use

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type

12.2.6.2. Market Revenue and Forecast, by Technology

12.2.6.3. Market Revenue and Forecast, by Display

12.2.6.4. Market Revenue and Forecast, by End-use

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type

12.2.7.2. Market Revenue and Forecast, by Technology

12.2.7.3. Market Revenue and Forecast, by Display

12.2.7.4. Market Revenue and Forecast, by End-use

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type

12.2.8.2. Market Revenue and Forecast, by Technology

12.2.8.3. Market Revenue and Forecast, by Display

12.2.8.4. Market Revenue and Forecast, by End-use

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type

12.3.2. Market Revenue and Forecast, by Technology

12.3.3. Market Revenue and Forecast, by Display

12.3.4. Market Revenue and Forecast, by End-use

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type

12.3.5.2. Market Revenue and Forecast, by Technology

12.3.5.3. Market Revenue and Forecast, by Display

12.3.5.4. Market Revenue and Forecast, by End-use

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type

12.3.6.2. Market Revenue and Forecast, by Technology

12.3.6.3. Market Revenue and Forecast, by Display

12.3.6.4. Market Revenue and Forecast, by End-use

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type

12.3.7.2. Market Revenue and Forecast, by Technology

12.3.7.3. Market Revenue and Forecast, by Display

12.3.7.4. Market Revenue and Forecast, by End-use

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type

12.3.8.2. Market Revenue and Forecast, by Technology

12.3.8.3. Market Revenue and Forecast, by Display

12.3.8.4. Market Revenue and Forecast, by End-use

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type

12.4.2. Market Revenue and Forecast, by Technology

12.4.3. Market Revenue and Forecast, by Display

12.4.4. Market Revenue and Forecast, by End-use

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type

12.4.5.2. Market Revenue and Forecast, by Technology

12.4.5.3. Market Revenue and Forecast, by Display

12.4.5.4. Market Revenue and Forecast, by End-use

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type

12.4.6.2. Market Revenue and Forecast, by Technology

12.4.6.3. Market Revenue and Forecast, by Display

12.4.6.4. Market Revenue and Forecast, by End-use

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type

12.4.7.2. Market Revenue and Forecast, by Technology

12.4.7.3. Market Revenue and Forecast, by Display

12.4.7.4. Market Revenue and Forecast, by End-use

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type

12.4.8.2. Market Revenue and Forecast, by Technology

12.4.8.3. Market Revenue and Forecast, by Display

12.4.8.4. Market Revenue and Forecast, by End-use

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type

12.5.2. Market Revenue and Forecast, by Technology

12.5.3. Market Revenue and Forecast, by Display

12.5.4. Market Revenue and Forecast, by End-use

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type

12.5.5.2. Market Revenue and Forecast, by Technology

12.5.5.3. Market Revenue and Forecast, by Display

12.5.5.4. Market Revenue and Forecast, by End-use

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type

12.5.6.2. Market Revenue and Forecast, by Technology

12.5.6.3. Market Revenue and Forecast, by Display

12.5.6.4. Market Revenue and Forecast, by End-use

Chapter 13. Company Profiles

13.1. GE Healthcare

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Koninklijke Philips

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Siemens Healthineers AG

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Hitachi Medical Corp.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Samsung Medison Co. Ltd.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Chison Wuxi Xiangsheng Medical Technology Co., Ltd.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Fujifilm Sonosite, Inc.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global cardiovascular ultrasound market size was accounted at USD 2.82 billion in 2024 and it is expected to reach around USD 5.30 billion by 2034.

The global cardiovascular ultrasound market is poised to grow at a CAGR of 6.51% from 2025 to 2034.

The major players operating in the cardiovascular ultrasound market are GE Healthcare, Koninklijke Philips, Siemens Healthineers AG, Hitachi Medical Corp., Samsung Medison Co. Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray), Chison Wuxi Xiangsheng Medical Technology Co., Ltd., Fujifilm Sonosite, Inc.

The main considerations for the development of the cardiovascular ultrasound framework market incorporate - the rising rate of cardiovascular sicknesses (CVDs), ascend in mechanical headways, and benefits of echocardiography over obtrusive heart demonstrative methodology.

North America region will lead the global cardiovascular ultrasound market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client